Indication
Adenosquamous Cell Lung Cancer
3 clinical trials
2 products
2 drugs
Clinical trial
Long-Term Follow-Up Study for Subjects Enrolled in the Phase I/II Study of Autologous T Cells Using the Sleeping Beauty System to Express T Cell Receptors (TCRs) Reactive Against Cancer-specific Mutations in Subjects With Solid TumorsStatus: Recruiting, Estimated PCD: 2039-04-01
Clinical trial
Phase I/II Study of Autologous T Cells Engineered Using the Sleeping Beauty System to Express T-Cell Receptors (TCRs) Reactive Against Cancer-specific Mutations in Subjects With Solid TumorsStatus: Active (not recruiting), Estimated PCD: 2025-12-01
Product
AldesleukinClinical trial
Image-Guided Hypofractionated Radiotherapy With Stereotactic Boost and Chemotherapy for Inoperable Stage II-III Non-Small Cell Lung CancerStatus: Active (not recruiting), Estimated PCD: 2025-01-31
Drug
carboplatinDrug
paclitaxel